BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16374652)

  • 1. The use of levo-carnitine in children with renal disease: a review and a call for future studies.
    Belay B; Esteban-Cruciani N; Walsh CA; Kaskel FJ
    Pediatr Nephrol; 2006 Mar; 21(3):308-17. PubMed ID: 16374652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-Carnitine and intestinal inflammation.
    Fortin G
    Vitam Horm; 2011; 86():353-66. PubMed ID: 21419279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine.
    Borum PR
    Annu Rev Nutr; 1983; 3():233-59. PubMed ID: 6357236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-carnitine supplementation in dialysis patients: does the evidence justify its use?
    Steinman TI
    Semin Dial; 2005; 18(1):1-2. PubMed ID: 15663752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levocarnitine and dialysis: a review.
    Schreiber B
    Nutr Clin Pract; 2005 Apr; 20(2):218-43. PubMed ID: 16207659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysis-related carnitine disorder.
    Hedayati SS
    Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
    Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in carnitine in chronic uremia.
    Guarnieri G; Biolo G; Vinci P; Massolino B; Barazzoni R
    J Ren Nutr; 2007 Jan; 17(1):23-9. PubMed ID: 17198928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of carnitine in pediatric nutrition.
    Crill CM; Helms RA
    Nutr Clin Pract; 2007 Apr; 22(2):204-13. PubMed ID: 17374794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure.
    Thompson CH; Irish AB; Kemp GJ; Taylor DJ; Radda GK
    Clin Nephrol; 1997 Jun; 47(6):372-8. PubMed ID: 9202867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-carnitine supplementation in dialysis: treatment in quest of disease.
    Wasserstein AG
    Semin Dial; 2013; 26(1):11-5. PubMed ID: 23173999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Carnitor for Epogen resistant anemia.
    Simard JC
    ANNA J; 1999 Feb; 26(1):41-2. PubMed ID: 10222857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference.
    Eknoyan G; Latos DL; Lindberg J;
    Am J Kidney Dis; 2003 Apr; 41(4):868-76. PubMed ID: 12666074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?
    Steinman TI; Nissenson AR; Glassock RJ; Dickmeyer J; Mattern WD; Parker TF; Hull AR
    Nephrol News Issues; 2003 Apr; 17(5):28-30, 32-4, 36 passim. PubMed ID: 12715624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease.
    Khurana M; Silverstein DM
    Pediatr Nephrol; 2015 Dec; 30(12):2073-84. PubMed ID: 25801207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease (NAFLD)--is it a new marker of hyporesponsiveness to recombinant human erythropoietin in patients that are on chronic hemodialysis?
    Orlic L; Mikolasevic I; Lukenda V; Racki S; Stimac D; Milic S
    Med Hypotheses; 2014 Dec; 83(6):798-801. PubMed ID: 25456789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carnitine metabolism in chronic kidney failure].
    Fiorini F; Patrone E; Castellucci A
    Clin Ter; 1992 Jan; 140(1 Pt 2):31-4. PubMed ID: 1559320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-carnitine supplementation in the dialysis population: are Australian patients missing out?
    Reuter SE; Faull RJ; Evans AM
    Nephrology (Carlton); 2008 Feb; 13(1):3-16. PubMed ID: 18199095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnitine in metabolic disease: potential for pharmacological intervention.
    Arduini A; Bonomini M; Savica V; Amato A; Zammit V
    Pharmacol Ther; 2008 Nov; 120(2):149-56. PubMed ID: 18793670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stereopharmacology of carnitine].
    Spasov AA; IIezhitsa IN
    Ross Fiziol Zh Im I M Sechenova; 2005 Dec; 91(12):1469-80. PubMed ID: 16493928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.